Drug Profile
Baclofen intrathecal injection - Piramal Enterprises
Alternative Names: GablofenLatest Information Update: 19 Dec 2021
Price :
$50
*
At a glance
- Originator CNS Therapeutics
- Developer CNS Therapeutics; Piramal Enterprises
- Class Aminobutyric acids; Antispastics; Muscle relaxants; Small molecules
- Mechanism of Action GABA B receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Muscle spasticity
Most Recent Events
- 20 Mar 2017 Mallinckrodt sold its Intrathecal Therapy Business of drugs for spasticity and pain management to Piramal Enterprises
- 13 Feb 2017 Chemical structure information added
- 30 Jan 2017 Piramal Enterprises enters into an agreement to acquire spasticity and pain management therapeutics including baclofen intrathecal injection from Mallinckrodt (9210845; 9210919)